☆ 4.6 Meeting Abstract

Potent in Vitro Activity of Tarloxotinib for HER2 Exon 20 Mutations in Lung Cancer and Mechanism of Acquired Resistance

JOURNAL OF THORACIC ONCOLOGY (2019)

Journal

JOURNAL OF THORACIC ONCOLOGY

Volume 14, Issue 10, Pages S690-S691

Publisher

ELSEVIER SCIENCE INC

DOI: 10.1016/j.jtho.2019.08.1467

Keywords

HER2; Exon 20; Tarloxotinib

Categories

Oncology Respiratory System

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.